1 active trials 0 recruiting 2 disease areas
| First posted | New trial filing | Phase | Status |
|---|---|---|---|
| 2026-09-04 | NCT07804901 Asciminib Frontline Risk Adapted | Phase 2 | Not Yet Recruiting |
| Phase 2 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2 | ||||
| NCT07804901 | Asciminib Frontline Risk Adapted | Chronic Myeloid Leukemia (CML) | Not Yet Recruiting | 2026-09-04 |
Chronic Myeloid Leukemia (CML) (1) · Leukemia (1)